PubMed

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.

Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW.

Malar J. 2007 May 29;6:72.PMID: 17535417 [PubMed - indexed for MEDLINE]Related articlesFree article

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.

Sipilanyambe N, Simon JL, Chanda P, Olumese P, Snow RW, Hamer DH.

Malar J. 2008 Jan 29;7:25.PMID: 18230140 [PubMed - indexed for MEDLINE]Related articlesFree article

Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.

Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW.

Trop Med Int Health. 2008 Jan;13(1):99-107.PMID: 18291008 [PubMed - indexed for MEDLINE]Related articlesFree article

[Combined antimalarial therapy using artemisinin]

Majori G.

Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian. PMID: 15305693 [PubMed - indexed for MEDLINE]Related articles

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

Malik EM, Mohamed TA, Elmardi KA, Mowien RM, Elhassan AH, Elamin SB, Mannan AA, Ahmed ES.

Malar J. 2006 Jul 31;5:65.PMID: 16879742 [PubMed - indexed for MEDLINE]Related articlesFree article

Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.

Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.

Malar J. 2009 Jan 5;8:2.PMID: 19123926 [PubMed - indexed for MEDLINE]Related articlesFree article

Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.

Nahum A, Erhart A, Gazard D, Agbowai C, Van Overmeir C, van Loen H, Menten J, Akogbeto M, Coosemans M, Massougbodji A, D'Alessandro U.

Malar J. 2007 Dec 21;6:170.PMID: 18154655 [PubMed - indexed for MEDLINE]Related articlesFree article

Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.

Mubyazi GM, Gonzalez-Block MA.

Malar J. 2005 Oct 20;4:51.PMID: 16242017 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.

Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S.

Malar J. 2007 Nov 11;6:146.PMID: 17996121 [PubMed - indexed for MEDLINE]Related articlesFree article

Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.

Tarimo DS, Malekela DA.

East Afr J Public Health. 2007 Apr;4(1):43-6.PMID: 17907761 [PubMed - indexed for MEDLINE]Related articles

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.

Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow RW.

BMJ. 2005 Oct 1;331(7519):734.PMID: 16195289 [PubMed - indexed for MEDLINE]Related articlesFree article

The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya.

Gitonga CW, Amin AA, Ajanga A, Kangwana BB, Noor AM, Snow RW.

Trop Med Int Health. 2008 Apr;13(4):487-94. Epub 2008 Feb 22.PMID: 18298605 [PubMed - indexed for MEDLINE]Related articlesFree article

Using evidence to change antimalarial drug policy in Kenya.

Shretta R, Omumbo J, Rapuoda B, Snow RW.

Trop Med Int Health. 2000 Nov;5(11):755-64.PMID: 11123822 [PubMed - indexed for MEDLINE]Related articlesFree article

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.

Wasunna B, Zurovac D, Goodman CA, Snow RW.

Malar J. 2008 Feb 5;7:29.PMID: 18252000 [PubMed - indexed for MEDLINE]Related articlesFree article

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.

Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW.

Malar J. 2008 Sep 19;7:181.PMID: 18803833 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.

Mukhtar EA, Gadalla NB, El-Zaki SE, Mukhtar I, Mansour FA, Babiker A, El-Sayed BB.

Malar J. 2007 Jul 15;6:92.PMID: 17631681 [PubMed - indexed for MEDLINE]Related articlesFree article

Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!

Mutabingwa TK.

Acta Trop. 2005 Sep;95(3):305-15. Review.PMID: 16098946 [PubMed - indexed for MEDLINE]Related articles

Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.

Njogu J, Akhwale W, Hamer DH, Zurovac D.

East Afr Med J. 2008 May;85(5):213-21.PMID: 18814531 [PubMed - indexed for MEDLINE]Related articlesFree article

A retrospective analysis of the change in anti-malarial treatment policy: Peru.

Williams HA, Vincent-Mark A, Herrera Y, Chang OJ.

Malar J. 2009 Apr 28;8:85. Review.PMID: 19400953 [PubMed - indexed for MEDLINE]Related articlesFree article

How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.

Nsimba SE.

J Ethnobiol Ethnomed. 2006 Jan 10;2:5.PMID: 16403225 [PubMed - indexed for MEDLINE]Related articlesFree article